2023
DOI: 10.1016/j.jconrel.2023.01.050
|View full text |Cite
|
Sign up to set email alerts
|

Deep eutectic solvents—Hydrogels for the topical management of rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 56 publications
0
9
0
Order By: Relevance
“…This formulated DES-MSN hydrogel system was applied to the skin of rats to test the skin irritation and the in vivo toxicity of this system. They observed a sustained penetration and accumulation of MSNs at subcutaneous inflammation sites [88].…”
Section: Animal Modelsmentioning
confidence: 98%
See 1 more Smart Citation
“…This formulated DES-MSN hydrogel system was applied to the skin of rats to test the skin irritation and the in vivo toxicity of this system. They observed a sustained penetration and accumulation of MSNs at subcutaneous inflammation sites [88].…”
Section: Animal Modelsmentioning
confidence: 98%
“…Previous studies are shown according to their routes of administration and are summarized in Table 3. Injection: topical and subcutaneous (in vivo) Arginine (Arg)-citric acid (CA) + Methotrexate Male Wistar rats [88] Oral (in vivo) Betaine, Mandelic acid (Bet-Man NADES) + RA-XII Healthy male Sprague Dawley rats [89] Oral (in vivo) Fumaric acid + Diacerein 2,4-dihydroxybenzoic acid + Diacerein Healthy Sprague Dawley rats [90,91] Oral (in vivo)…”
Section: Animal Modelsmentioning
confidence: 99%
“…itraconazole [a] anti-fungal [136] posaconazole [a] anti-fungal choline chloride glycolic acid piroxicam [a] non-steroidal anti-inflammatory drug solubility enhancement of itraconazole, piroxicam, lidocaine, and posaconazole by 6700, 430, 28, and 6400-fold, respectively, as compared to their water solubility lidocaine [a] local anesthetic choline chloride propylene glycol dapsone [a] FDA-approved for acne treatment. It also has therapeutic activities for a range of dermatological diseases solubility enhancement and topical delivery of dapsone with solubility of 500 mg/mL in DES compared with its solubility in water (380 mg/L) [137] betaine ethylene glycol mesalazine [a] treatment of Crohn's disease and ulcerative colitis the mesalazine solubility in DES + water mixtures increased by increasing mass fractions of DES [138] choline (or acetyl choline) glycolate, lactate, propionate, hexenoate, or geranate insulin [a] and monoclonal antibodies subcutaneous delivery of protein therapeutics incorporation of insulin and monoclonal antibodies in DESs showed an improvement in the pharmacokinetics of insulin and the bioavailability of monoclonal antibodies [139] citric acid arginine mesoporous silica nanoparticles containing nanoceria and methotrexate topical management of rheumatoid arthritis using DES-NPs hydrogel DES-NPs hydrogel formulation resulted in sustained penetration and accumulation of NPs at rheumatoid arthritis sites [140] choline chloride malonic acid tadalafil [a] wound healing and antimicrobial activity tadalafil was dissolved in DES for topical application to avoid systemic exposure. Then, Lidocaine was added to the formulation to provide a local anesthetic effect.…”
Section: Des As a Solvent For Active Pharmaceutical Ingredientsmentioning
confidence: 99%
“…1,2 Particularly, this approach has shown great success in cancer treatment. 3,4 For instance, monoclonal antibodies targeting specific proteins on cancer cells can effectively block or modulate cancerpromoting signals, leading to improved patient outcomes. 5,6 Ribonuclease A (RNase A) is a naturally occurring protein that has gained significant attention in the field of protein therapy, [7][8][9] as it can specifically recognize and bind to the abnormal RNA structure and further cleave the dysregulated RNA molecules to induce the apoptosis of cancer cells.…”
Section: Introductionmentioning
confidence: 99%